Gelsolin-related familial amyloidosis, Finnish type (FAF), and its variants found worldwide

Amyloid

Volumn 5, Issue 1, 1998, Pages 55-66

  Kiuru, Sari ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Actin binding protein; Amyloid angiopathy; Corneal lattice dystrophy; Cranial neuropathy; Familial amyloidosis; Finnish type; Gelsolin; Hereditary amyloidosis; Polyneuropathy; Skin amyloidosis

Indexed keywords

AMYLOID; AMYLOID AGEL PROTEIN, HUMAN; PEPTIDE FRAGMENT;

AMYLOID NEUROPATHY; CHEMISTRY; DOMINANT GENE; FEMALE; GENETICS; HUMAN; MALE; MUTATION; PATHOPHYSIOLOGY; REVIEW;

AMYLOID; AMYLOID NEUROPATHIES; FEMALE; GENES, DOMINANT; HUMANS; MALE; MUTATION; PEPTIDE FRAGMENTS;

EID: 0032012657     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.3109/13506129809007291     Document Type: Review

References (85)

1. Meretoja J (1969). Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms. A previously unrecognized heritable syndrome. Ann Clin Res 1, 314-324
2. McKusick VA (1990). Mendelian Inheritance in Man, pp.58-59. (Baltimore: Johns Hopkins University Press)
3. Maury CPJ, Alli K and Baumann M (1990). Finnish hereditary amyloidosis. Amino acid sequence homology between the amyloid fibril protein and human plasma gelsoline. FEBS Lett 260, 85-87
4. Haltia M, Prelli F, Ghiso J, Kiuru S, Somer H, Palo J and Frangione B (1990). Amyloid protein in familial amyloidosis (Finnish type) is homologous to gelsolin, an actin-binding protein. Biochem Biophys Res Commun 167, 927-932
5. Husby G, Araki A, Benditt EP, Benson M, Cohen A, Frangione B, Glenner GG, Natvig JB and Westermark P (1991). The 1990 guidelines for nomenclature and classification of amyloid and amyloidosis. In Natvig JB, Forre O, Husby G, Husebekk A, Skogen B, Sletten K and Westermark P(eds). Amyloid and Amyloidosis 1990, pp.7-11. (Dordrecht: Kluwer Academic Publishers)
6. Meretoja J and Teppo L (1971). Histopathological findings of familial amyloidosis with cranial neuropathy as principal manifestation. Report of three cases. Acta Path Microbiol Scand [Sect A] 79, 432-440
7. Meretoja J ( 1972). Comparative histopathological and clinical findings in eyes with lattice corneal dystrophy of two different types. Ophthalmologica 165,15-37
8. Meretoja J, Jokinen EJ, Collan Y and Lähdevirta J (1972). Renal biopsy findings in familial amyloidosis with corneal lattice dystrophy. Acta Path Microbiol Scand [Sect A] 80, 228-238
9. Kaunisto N (1973). Lattice dystrophy of the cornea. Acta Ophthalmologica 51, 335-352
10. Meretoja J (1973). Genetic aspects of familial amyloidosis with corneal lattice dystrophy and cranial neuropathy. Clin Genet 4, 173-185
11. Meretoja J and Tarkkanen A (1975). Pseudoexfoliation syndrome in familial systemic amyloidosis with lattice corneal dystrophy. Ophthalmic Res 7, 194-203
12. Meretoja J (1976). Tautiperintöämme: suomalainen amyloiditauti (The Finnish amyloid disease representing our disease inheritage). Suomen lääkärilehti (J Finn Med Assoc) 31, 2234-2236 (in Finnish)
13. Collan Y and Meretoja J (1978). Inherited systemic amyloidosis (Finnish type): Ultrastructure of the skin. Ann Clin Res 10, 43-47
14. Rintala AE, Alanko A, Mäkinen J, Nordström R and Salo H (1988). Primary hereditary systemic amyloidosis (Meretoja's syndrome): clinical features and treatment by plastic surgery. Scand J Plast Reconstr Surg 22, 141-145
15. Haltia M, Ghiso J, Prelli F, Gallo G, Kiuru S, Somer H, Palo J and Frangione B (1990). Amyloid in familial amyloidosis, Finnish type, is antigenically and structurally related to gelsolin. Am J Pathol 136, 1223-1228
16. Levy E, Haltia M, Fernandez-Madrid I, Koivunen O, Ghiso J, Prelli F and Frangione B (1990). Mutation in gelsolin gene in Finnish hereditary amyloidosis. J Exp Med 172, 1865-1867
17. Maury CPJ, Kere J, Tolvanen R and de la Chapelle A (1990). Finnish hereditary amyloidosis is caused by a single nucleotide substitution in the gelsolin gene. FEBS Lett 276, 75-77
18. Hiltunen T, Kiuru S, Hongell V, Heliö T, Palo J and Peltonen L (1991). Finnish type of familial amyloidosis: cosegregation of ASP187->ASN mutation of gelsolin with the disease in three large families. Am J Hum Genet 49, 522-528
19. de la Chapelle A, Kere J, Sack GH Jr, Tolvanen R and Maury CPJ (1992). Familial amyloidosis, Finnish type: G654->A mutation of the gelsolin gene in Finnish families and an unrelated American family. Genomics 1, 898-901
20. de la Chapelle A, Tolvanen R, Boysen G, Santavy J, Bleeker-Wagemakers L, Maury CPJ and Kere J (1992). Gelsolin-derived familial amyloidosis caused by asparagine or tyrosine substitution for aspartic acid at residue 187. Nature Genet 2, 157-160
21. Haltia M, Levy E, Meretoja J, Fernandez-Madrid I, Koivunen O and Frangione B (1992). Gelsolin gene mutation- at codon 187- in familial amyloidosis, Finnish: DNA-diagnostic assay. Am J Med Genet 42, 357-359
22. Kiuru S (1992). Familial amyloidosis of the Finnish type (FAF)- A clinical study of 30 patients. Acta Neurol Scand 86, 346-353
23. Maury CPJ, Kere J, Tolvanen R and de la Chapelle A ( 1992). Homozygosity for the Asn187 gelsolin mutation in Finnish-type familial amyloidosis is associated with severe renal disease. Genomics 13, 902-903
24. Paunio T, Kiuru S, Hongell V, Mustonen E, Syvänen AC, Bengtström M, Palo J and Peltonen L (1992). Solid-phase minisequencing test reveals Asp187-> Asn (G654->A) mutation of gelsolin in all affected individuals with Finnish type of familial amyloidosis. Genomics 13, 237-239
25. Kivelä T, Tarkkanen A, McLean I, Ghiso J, Frangione B and Haltia M (1993). Immunohistochemical analysis of lattice corneal dystrophies types I and II. Br J Ophthalmol 77, 799-804
26. Kiuru S and Seppäläinen AM (1994). Neuropathy in familial amyloidosis, Finnish type (FAF): Electrophysiological studies. Muscle Nerve 17, 299-304
27. Kiuru S, Matikainen E, Kupari M, Haltia M and Palo J (1994) Autonomic nervous system and cardiac involvement in familial amyloidosis, Finnish type (FAF). J Neurol Sci 126, 40-48
28. Kivelä T, Tarkkanen A, Frangione B, Ghiso J and Haltia M (1994). Ocular amyloid deposition in familial amyloidosis, Finnish: an analysis of native and variant gelsolin in Meretoja's syndrome. Invest Ophthalmol Vis Sci 35, 3759-3769
29. Kiuru S, Seppäläinen AM, Salonen O, Hokkanen L, Somer H and Palo J (1995). CNS abnormalities in patients with familial amyloidosis of the Finnish type (FAF). Amyloid: Int J Exp Clin Invest 2, 22-30
30. Paunio T, Sunada Y, Kiuru S, Makishita H, Ikeda S, Weissenbach J, Palo J and Peltonen L (1995). Haplotype analysis in gelsolin-related amyloidosis reveals independent origin of identical mutation (G645A) of gelsolin in Finland and Japan. Hum Mut 6, 60-65
31. Winkelman JE, Delleman JW and Ansink BJJ (1971). Ein hereditäres Syndrom, bestehend aus peripherer Polyneuropathie, Hautveränderungen und gittriger Dystrophie der Hornhaut. Klin Mbl Augenhk 159, 618-623
32. Boysen G, Galassi G, Kamieniecka Z, Schlaeger J and Trojaborg W (1979). Familial amyloidosis with cranial neuropathy and corneal lattice dystrophy. J Neurol Neurosurg Psychiatry 42, 1020-1030.
33. Sack GH, Dumars KW, Gummerson KS, Law A and McKusick VA (1981). Three forms of dominant amyloid neuropathy. Johns Hopkins Med 149, 239-247
34. Purcell JJ Jr, Rodrigues M, Chishti I, Riner RN and Dooley JM (1983). Lattice corneal dystrophy associated with familial systemic amyloidosis (Meretoja's syndrome). Ophthalmology 90, 1512-1517
35. Starck T, Kenyon KR, Hanninen LA, Beyer-Machule C, Fabian R, Gorn RA, McMullan FD, Baum J and McAdam KPWJ (1991). Clinical and histopathologic studies of two families with lattice corneal dystrophy and familial systemic amyloidosis (Meretoja syndrome). Ophthalmology 98, 1197-1206
36. Hanninen LA, Gilbard JP, Wang SJ and Kenyon KR (1985). Familial systemic amyloidosis with lattice corneal dystrophy. In Henkes HE, Ahonen R and Karjalainen K (eds). Proceedings of the VIIth Congress of the European Society of Ophthalmology, pp. 438-440. (Helsinki: The Society)
37. Darras BT, Adelman LS, Mora JS, Bodziner RA and Munsat TL (1986). Familial amyloidosis with cranial neuropathy and corneal lattice dystrophy. Neurology 36, 432-435
38. Steiner RD, Paunio T, Uemichi T, Evans JP and Benson M (1995). Aspl87Asn mutation of gelsolin in an American kindred with familial amyloidosis, Finnish type (FAF) Hum Genet 95, 327-330
39. Sunada Y, Shimizu T, Nakase H, Ohta S, Asaoka T, Amano S, Sawa M, Kagawa Y, Kanazawa I and Mannen T (1993). Inherited amyloid polyneuropathy type IV (gelsolin variant) in a Japanese family. Ann Neurol 33, 57-62
40. Yazaki M, Makishita H, Yazawa M, Ikeda S-I and Yanagisawa N (1994). Clinicopathological study of type IV familial amyloid polyneuropathy in Japan. In Kisilevsky R, Benson MD, Frangione B, Gauldie J, Muckle TJ and Young ID(eds). Amloid and Amyloidosis 1993, pp.688-690. (New York: Parthenon Publishing)
41. Akiya S, Nishio Y, Ibi K, Uozumi H, Takahashi H, Hamada T, Onishi A, Ischiguchi H, Hoshii Y and Nakazato M (1996). Lattice corneal dystrophy type II associated with familial amyloid polyneuropathy type IV. Ophthalmology 103, 1106-1110
42. Makishita H, Ikeda S, Yazaki M, Yamane M, Yomoto K, Maury CPJ and Yanagisawa N (1996). Postmortem pathological findings in a Japanese patient with familial amyloidosis, Finnish type (FAF). Amyloid: Int J Exp Clin Invest 3, 134-139
43. Klaus E, Freyberger E, Kavka G and Vodicka F (1959). Familiäres Vorkommen von bulbärparalytischer Form der amyotrophischen Lateralsklerose mit gittriger Hornhautdystrophie und Cutis hyperelastica bei drei Schwestern. Psychiatr Neurol 138, 79-97
44. Gorevic PD, Munoz PC, Gorgone G, Purcell JJ Jr, Rodriques M, Ghiso J, Levy E, Haltia M and Frangione B (1991). Amyloidosis due to a mutation of the gelsolin gene in an American family with corneal lattice dystrophy type II. New Engl J Med 325, 1780-1785
45. Vrabec FR (1957). Etude neurohistologique d'un cas de dystrophie grillagée de la cornée. Ophthalmologica 133, 160-169
46. Miller CA and Krachmer JH (1988). Epithelial and stromal dystrophies. In Kaufman HE, Barron BA, McDonald MB and Waltman SR (eds). The Cornea, pp.404-409. (New York: Churchill Livingstone)
47. Gorevic PD and Rodriques MM (1994). Ocular amyloidosis. Am J Ophthalmol 117, 529-532
48. Haltia M, Ghiso J, Wisniewski T, Kiuru S, Miller D and Frangione B(1991). Gelsolin variant and β-amyloid co-occur in a case of Alzheimer's with Lewy bodies. Neurobiol Aging 12, 313-316
49. Paunio T, Kiuru S, Karonen SL, Palo J and Peltonen L (1994). Quantification of serum and cerebrospinal fluid gelsolin in familial amyloidosis, Finnish type (AGel). Amyloid: Int J Exp Clin Invest 1, 80-89
50. Donders PC and Blanksma LJ (1979). Meretoja syndrome. Lattice dystrophy of the cornea with hereditary generalized amyloidosis. Ophthalmologica 178, 173-180
51. Ghiso J, Haltia M, Prelli F, Novelle J and Frangione B (1990). Gelsolin variant (Asn-187) in familial amyloidosis, Finnish type. Biochem J 272, 827-830
52. Maury CPJ and Baumann M (1990). Isolation and characterization of cardiac amyloid in familial amyloid polyneuropathy type IV (Finnish): relation of the amyloid protein to variant gelsolin. Biochim Biophys Acta 1096, 84-86
53. Maury CPJ (1991). Immunohistochemical localization of amyloid in Finnish hereditary amyloidosis with antibodies to gelsolin peptides. Lab Invest 64, 400-404
54. Rodriques MM, Rajagopalan S, Jones K, Nirankari V, Wisniewski T, Frangione B and Gorevic PD (1993). Gelsolin immunoreactivity in corneal amyloid, wound healing, and macular and granular dystrophies. Am J Ophthalmol 115, 644-652
55. Loeffler KU, Edvard DP and Tso MOM (1992). An immunohistochemical study of gelsolin immunoreactivity in corneal amyloidosis. Am J Ophthalmol 11, 547-554
56. Meretoja J (1976). Inherited systemic amyloidosis with corneal lattice dystrophy and cranial neuropathy. In Wegelius O and Pasternack A (eds). Amyloidosis, pp. 195-209. (London: Academic Press)
57. Tanaka M, Müllauer L, Ogiso Y, Fujita H, Moriya S, Furuuchi K, Harabayashi T, Shinohara N, Koyanagi T and Kuzumaki N (1995). Gelsolin: a candidate for suppressor of human bladder cancer. Cancer Research 55, 3228-3232
58. Kwiatkowski DJ, Stossel TP, Orkin SH, Mole JE, Colten HR and Yin HL (1986). Plasma and cytoplasmic gelsolins are encoded by a single gene and contain a duplicated actin-binding domain. Nature 323, 455-458
59. Kwiatkowski DJ, Westbrook CA, Bruns GAP and Morton C (1988). Localization of gelsolin proximal to ABL on chromosome 9. Am J Hum Genet 42, 565-572
60. Kwiatkowski DJ, Mehl R and Yin HL (1988). Genomic organisation and biosynthesis of secreted and cytoplasmic forms of gelsolin. J Cell Biol 106, 375-384
61. Yin H, Kwiatkowski DJ, Mole JE and Cole FS (1984). Structure and biosynthesis of cytoplasmic and secreted variants of gelsolin. J Biol Chem 259, 5271-5276
62. Paunio T, Kangas H, Kalkkinen N, Haltia M, Palo J and Peltonen J (1994). Towards understanding the pathogenetic mechanisms in gelsolin-related amyloidosis: in vitro expession reveals an abnormal gelsolin fragment. Hum Mol Genet 3, 2223-2229
63. Kangas H, Paunio T, Kalkkinen N, Jalanko A and Peltonen L (1996). In vitro expression analysis shows that the secretory form of gelsolin is the sole source of amyloid in gelsolin-related amyloidosis. Hum Mol Genet 5, 1237-1243
64. Maury CPJ (1991). Gelsolin-related amyloidosis. Identification of the amyloid protein in Finnish hereditary amyloidosis as a fragment of variant gelsolin. J Clin Invest 87, 1195-1199
65. Maury CPJ, Nurmiaho-Lassila EL and Rossi H (1994). Amyloid fibril formation in gelsolin-derived amyloidosis. Definition of the amyloidogenic region and evidence of accelerated amyloid formation of mutant Asn-187 and Tyr-187 gelsolin peptides. Lab Invest 70, 558-564
66. Maury CPJ and Nurmiaho-Lassila EL (1992). Creation of amyloid fibrils from mutant ASN 187 gelsolin peptides. Biochem Biophys Res Commun 183, 227-231
67. Soto C, Castaño EM, Prelli F, Kumar RA and Baumann M (1995). Apolipoprotein E increases the fibrillogenic potential of synthetic peptides derived from Alzheimer's, gelsolin and AA amyloids. FEBS Lett. 371, 110-114
68. McLaughlin PJ, Gooch JT, Mannherz HG and Weeds AG (1993). Structure of gelsolin segment 1-actin complex and the mechanism of filament severing. Nature 364, 685-692
69. Maury CPJ and Rossi H (1993). Demonstration of a circulating 65 K gelsolin variant specific for familial amyloidosis, Finnish type. Biochem Biophys Res Commun 191, 41-44
70. Sunada Y, Sakurai T, Nonomura Y and Kanazawa I (1994). Abnormal gelsolin fragments in the plasma of patients with familial amyloidosis of the Finnish type. In Kisilevsky R, Benson MD, Frangione B, Gauldie J, Muckle TJ and Young ID (eds). Amyloid and Amyloidosis 1993, pp. 623-625. (New York: Parthenon Publishing)
71. Paunio T, Kangas H, Kiuru S, Jorma P, Peltonen L and Syvänen AC (1997). Tissue distribution and levels of gelsolin mRNA in normal individuals and patients with gelsolin-related amyloidosis. FEBS Lett. 406, 49-55
72. Yin HL, Albrecht JH and Fattoum A (1981). Identification of gelsolin, a Ca2+-dependent regulatory protein of actin gel-sol transformation, and its intracellular distribution in a variety of cells and tissues. J Cell Biol 91, 901-906
73. Kwiatkowski DJ, Mehl R, Izumo S, Nada-Ginard B and Yin H (1988). Muscle is the major source of plasma gelsolin. J Biol Chem 263, 8239-8243
74. Tanaka J, Kira M and Sobue K (1993). Gelsolin is localized in neuronal growth cones. Dev Brain Res 76, 268-271
75. Léna JY, Legrand CH, Faivre-Sarrailh C, Sarliève LL, Ferraz C and Rabié A (1994). High gelsolin content of developing oligodendrocytes. Int J Devl Neuroscience 12, 375-386
76. Tanaka J and Sobue K (1994). Localization and characterization of gelsolin in nervous tissues: gelsolin is specifically enriched in myelin-forming cells. J Neurosci 12, 375-386
77. Schwartz SB, Higgins PJ, Rajasekaran AK and Staiano-Coico L (1994). Growth and differentiation of normal human keratinocytes in culture: modulation of gelsolin expression.. J Burn Care Rehabil 15, 478-485
78. Nodes B, Shackelford JE and Lebherz HG (1987). Synthesis and secretion of serum gelsolin by smooth muscle tissue. J Biol Chem 262, 5422-5427
79. Dißmann E and Hinssen H (1994). Immunocytochemical localization of gelsolin in fibroplasts, myogenic cells, and isolated myofibrils. Eur J Cell Biol 63, 336-344
80. Witke W, Sharpe AH, Hartwig JH, Azuma T, Stossel TP and Kwiatkowski DJ (1995). Hemostatic, inflammatory, and fibroblast responses are blunted in mice lacking gelsolin. Cell 81, 41-51
81. Hartwig JH, Bokoch GM, Carpenter CL, Jamney PA, Taylor LA, Toker A and Stossel TP (1995). Thrombin receptor ligation and activated rac uncap actin filament barbed ends through phoshoinositide synthesis in permeabilized human platelets. Cell 82, 643-653
82. Chen P, Murphy-Ullrich JE and Wells A (1996). A role for gelsolin in actuating epidermal growth factor receptor-mediated cell motility J Cell Biol 134, 689-698
83. Lee WM and Galbraith RM (1992). The extracellular actin-scavenger system and actin toxicity. N Engl J Med 326, 1335-1341
84. Way M and Weeds A (1988). Nucleotide sequence of pig plasma gelsolin: comparison of protein sequence with human gelsolin and other actin-severing proteins shows strong homologies and evidence for large internal repeats. J Mol Biol 203, 1127-1133
85. Weeds AG, Gooch J, McLaughlin P and Maury CPJ (1993). Variant plasma gelsolin responsible for familial amyloidosis (Finnish type) has defective actin severing activity. FEBS Lett 335, 119-123